Qelbree ER 200 MG capsule 60S
Ended Awarded
- Contract number
- SPE2DB25FN2QE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,845
Award facts
- Contract value 100% obligated
- $12,845.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,845.01 to AmerisourceBergen Drug Corp for the supply of QELBREE ER 200 MG capsules (60-count units), with an ultimate completion date of June 18, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded on June 17, 2025, with performance to be executed from the vendor's location in Conshohocken, Pennsylvania. QELBREE (viloxazine extended-release) is an FDA-approved medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult populations.
This delivery order is executed under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to fulfill federal medical procurement requirements through open competition across a diverse portfolio of therapeutic domains and contract values.
Quick answers
Who was awarded contract SPE2DB25FN2QE?
SPE2DB25FN2QE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 17, 2025.
How much is contract SPE2DB25FN2QE worth?
The government has obligated $12,845 on SPE2DB25FN2QE.
Is contract SPE2DB25FN2QE an order under another contract?
Yes. SPE2DB25FN2QE is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN2QE competed?
The extent of competition for SPE2DB25FN2QE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award